Zim Laboratories Ltd Share Price & Stock Analysis

Zim Laboratories Ltd (BSE: 541400) is a Nagpur, Maharashtra-based company in the Medicinal Chemicals and Botanical Products industry. With a market capitalisation of ₹755 Cr, it ranks #1,751 by market cap among the 6,197 Indian listed companies on FinBizNet, and #51 of 86 in Medicinal Chemicals and Botanical Products. At ₹139.55 (as of 16 Nov 2026), the share price is 12.7% below its 52-week high of ₹159.81 and 135.3% above its 52-week low of ₹59.31. The share price is up 98.4% over one year and up 28.4% over three months.

Key Metrics

Current Price₹139.55
Market Cap₹755 Cr
BSE Code541400
SectorHealth Care > Pharmaceuticals, Biotechnology and Life Sciences > Pharmaceuticals
Sub-IndustryBiotechnology and Life Sciences > Medicinal Chemicals and Botanical Products
P/E Ratio119.3
Return on Equity2.13%
Return on Assets1.27%
52-Week Range₹59.31 – ₹159.81
1-Year Price Change+98.4%
3-Month Price Change+28.4%
Beta (1Y)0.81
Dividend Yield0.00%
HeadquartersNagpur, Maharashtra
Websitewww.zimlab.in

Latest Quarterly Results — Q2 FY27

Revenue₹105 Cr
Net Profit₹-2 Cr
Net Margin-1.9%
EPS (Basic)₹-0.38
Basisconsolidated

Figures in ₹ crore, parsed from the company's exchange filing (XBRL).

Zim Laboratories Ltd Quarterly Revenue and Profit Trend

Zim Laboratories Ltd reported revenue of ₹105 Cr in Q2 FY27, up 18.9% from ₹89 Cr in Q2 FY26 and up 12.0% from ₹94 Cr in Q1 FY27. It posted a net loss of ₹2 Cr for the quarter, against a net loss of ₹0 Cr in Q2 FY26. Across the 7 quarters from Q4 FY25 to Q2 FY27, quarterly revenue ranged from ₹72 Cr (Q1 FY26) to ₹109 Cr (Q4 FY25). The company reported a net loss in 4 of these 7 quarters.

QuarterRevenueNet ProfitNet Margin
Q2 FY27₹105 Cr−₹2 Cr−1.9%
Q1 FY27₹94 Cr−₹4 Cr−4.3%
Q4 FY26₹105 Cr₹4 Cr3.6%
Q3 FY26₹109 Cr₹4 Cr4.0%
Q2 FY26₹89 Cr−₹0 Cr−0.5%
Q1 FY26₹72 Cr−₹2 Cr−2.6%
Q4 FY25₹109 Cr₹5 Cr4.5%

Consolidated figures (₹ crore, XBRL filings).

Shareholding and Delivery

Promoters held 30.30% of Zim Laboratories Ltd's shares as of Sept 2026, against 33.26% in Sept 2025 (−2.96 percentage points). Delivery averaged 48.9% of traded volume across 16 NSE sessions (22 Oct 2026 – 13 Nov 2026).

About Zim Laboratories Ltd

ZIM Laboratories Limited engages in the development, manufacture, and supply of generic pharmaceutical and nutraceutical products in India and internationally. It provides its products in pre- formulation intermediates and finished formulations in the oral solid dosage forms, such as pellets, taste-masked powders, granules, tablets, capsules, dry syrup, and oral thin films. The company offers therapeutics in the areas of urology, gastroenterology, antibiotics, anti-infectives, cardiovascular, central nervous system, NSAIDs/pain analgesics, and vitamins and supplements. The company was incorporated in 1984 and is based in Nagpur, India.

Products and Services

1. Pharmaceuticals-This segment manufactures, markets, and sells formulation drugs and pre formulation ingredients.

Business Segments

1. Pharmaceuticals-100%

Zim Laboratories Ltd vs Peers — Medicinal Chemicals and Botanical Products

CompanyMarket CapP/EROELatest Qtr Revenue1Y Change
Sun Pharmaceutical Industries Limited₹4,56,425 Cr39.514.72%₹16,199 Cr+11.2%
Laurus Labs Ltd₹1,31,242 Cr145.617.74%₹2,206 Cr+146.8%
Zydus Lifesciences Ltd₹1,19,651 Cr24.118.32%₹7,910 Cr+26.0%
Dr.Reddys Lab₹1,15,464 Cr26.911.52%₹8,698 Cr+14.5%
Cipla Limited₹1,14,712 Cr29.311.74%₹7,404 Cr-7.6%
Mankind Pharma₹1,09,870 Cr5712.45%₹4,338 Cr+16.7%
Aurobindo Pharma Ltd.₹1,05,150 Cr309.93%₹10,263 Cr+59.8%
Lupin Ltd₹92,087 Cr17.326.91%₹7,827 Cr+0.4%
Zim Laboratories Ltd₹755 Cr119.32.13%₹105 Cr+98.4%

Listed by market capitalisation. Ratios are shown for context only.

Frequently Asked Questions

What is the current share price of Zim Laboratories Ltd?

Zim Laboratories Ltd is trading at ₹139.55, with a market capitalisation of ₹755 Cr.

Which sector does Zim Laboratories Ltd belong to?

Zim Laboratories Ltd operates in the Health Care > Pharmaceuticals, Biotechnology and Life Sciences > Pharmaceuticals space (Biotechnology and Life Sciences > Medicinal Chemicals and Botanical Products).

What are the key financial ratios of Zim Laboratories Ltd?

Zim Laboratories Ltd has a P/E of 119.3 and a return on equity of 2.13%.

What is the stock symbol of Zim Laboratories Ltd?

Zim Laboratories Ltd is listed on the BSE under the scrip code 541400.

How has Zim Laboratories Ltd's share price moved over the past year?

Zim Laboratories Ltd's share price is up 98.4% over one year and up 28.4% over three months. Its 52-week range is ₹59.31 to ₹159.81.

What were Zim Laboratories Ltd's latest quarterly results?

In Q2 FY27, Zim Laboratories Ltd reported revenue of ₹105 Cr and net profit of ₹-2 Cr, with basic EPS of ₹-0.38 (consolidated, parsed from the company's exchange filing).

How have Zim Laboratories Ltd's revenue and profit changed over the past year?

Zim Laboratories Ltd reported revenue of ₹105 Cr in Q2 FY27, up 18.9% from ₹89 Cr in Q2 FY26 and up 12.0% from ₹94 Cr in Q1 FY27.

What is the promoter holding in Zim Laboratories Ltd?

Promoters held 30.30% of Zim Laboratories Ltd's shares as of Sept 2026, against 33.26% in Sept 2025 (−2.96 percentage points).

More on FinBizNet

Data as of 16 Nov 2026. Descriptive market data only — not investment advice.